Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR Study

1. Capdevila, J.
2. Teulé, A.
3. Barriuso, J.
4. Castellano, D.
5. Lopez, C.
6. Manzano, J.L.
7. Alonso, V.
8. García-Carbonero, R.
9. Dotor, E.
10. Matos, I.
11. Custodio, A.
12. Casanovas, O.
13. Salazar, R.